# Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers

> **NCT03873324** · PHASE1 · COMPLETED · sponsor: **Celon Pharma SA** · enrollment: 56 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** CPL500036 compound
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03873324
- **Lead sponsor:** Celon Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-20
- **Primary completion:** 2019-09-16
- **Final completion:** 2019-09-16
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2019-10-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03873324

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03873324, "Safety and Pharmacokinetics Study of CPL500036 Compound in Healthy Volunteers". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT03873324. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*